| USAN | PEXELIZUMAB |
|---|---|
| Code Desination | h5G1.1 scFv; h5G1.1 scFv (CDR) |
| Chemical Name | immunoglobulin (human-mouse monoclonal 5G1.1-SC single chain anti-human complement C5 α-chain) |
| CAS No. | N/A |
| Mol. Wt. | 26,500 D |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Therapeutic Claim | complement inhibitor used to reduce the impact of complement-mediated injuries sustained during cardiopulmonary bypass (humanized monoclonal antibody) |
| Added Date | 2000 |
| File | PDF |
Extended Information